Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

SHANGHAI - Swiss pharmaceutical giant Roche has announced plans to invest 2.04 billion yuan ($283 million) in building a new ...

RHHBY unveiled plans to invest over $700 million in a new 700,000-square-foot, state-of-the-art drug manufacturing facility ...

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Under the agreement, AstraZeneca will establish a global strategic R&D center in Beijing ... Also in March, US-based pharmaceutical company Eli Lilly launched Lilly Gateway Labs in Beijing ...

Commerce officials approved an incentives package worth up to $13.1 million for the company, which plans to build a $700 million plant in the Wake County town. It's the latest drugmaker to target the ...

NKTR incurs a wider-than-expected loss in the first quarter of 2025. Revenues plunge year over year. Shares fall in after-hours trading.

Eli Lilly seems to have responded to the threat ... and reduced investment in R&D. Lilly's announcement comes just a few days after Lilly's chief executive, David Ricks, and other pharma leaders ...